Kyorin Pharmaceuticals Articles
Astellas and Ambrx collaborate in up to $300 oncology deal; Teijin takes stake in Kyorin
5 April 2013
Forest launches COPD product Tudorza in USA
12 December 2012
Kyorin Pharma transfers Pekiron rights to Galderma
11 October 2012
SkyePharma partner Kyorin files for Flutiform approval in Japan
26 September 2012
Showing 1-6 of 6 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
